Peer Approaches to Lupus Self-management
Part of paid clinical trials in Charleston, South Carolina.
- Sponsor
- Medical University of South Carolina
- Study ID
- NCT03734055
- Status
- Active Not Recruiting
Conditions
- Behavior, Health
- Quality of Life
- Systemic Lupus Erythematosus
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Peer Mentoring — BEHAVIORALManualized peer mentorship program designed to provide modeling and reinforcement by peers (mentors) to other African American women with SLE (mentees) to encourage them to engage in activities that promote disease self-management.
- Social Support Group — BEHAVIORALSocial support controls will participate in a lupus support group created for this project, on the same schedule as peer mentoring sessions.
Study Details
The Peer Approaches to Lupus Self-Management (PALS) study is a randomized, controlled in which 360 African American women with lupus will be recruited from the MUSC SLE database (60 mentors and 300 mentees). The peer mentoring intervention (patients will be matched with peer mentors who are considered competent in the management of their condition to provide modeling and reinforcement to participants) will occur by telephone for approximately 60 minutes every two weeks for 24 weeks. All participants will be assessed at baseline, mid-intervention (12 weeks post-enrollment), immediately following the intervention (24 weeks post-enrollment), and 12 months post-enrollment. The study will last 60 months with recruitment and enrollment over 48 months, 6 months for intervention delivery and 6 months for data analysis.
Key Dates
- Start date
- Nov 30, 2018
- Status verified
- Aug 2025
- Primary completion
- Apr 23, 2023
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 314 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Peer MentoringThe program will consist of 12 sessions of peer mentoring that will include one standard educational session by telephone or video for approximately 60 minutes every 2 weeks. Additional interaction will be discouraged, but mentees and mentors will be asked to report any additional social interaction should it occur. The bi-weekly educational session will be generally structured in three parts: introduction, structured education, and problem solving. 60-minute calls are necessary for the delivery of educational content and mentors and mentees to be able to discuss their own experiences and potential solutions.
- Active Comparator: Social Support GroupMentees randomized to the social support control group will be enrolled in a lupus support group designed specifically for this project.
- No Intervention: Peer MentorsThe principal roles of the peer mentors are to: 1) provide information about SLE, SLE-related behaviors, thoughts, and feelings, and the nature of recommended treatments; 2) provide social support to alleviate the mentee's sense of social isolation; 3) enhance and reinforce the mentee's sense of self-efficacy to manage their condition; and 4) encourage the mentee to participate actively in the recommended self-management skills building therapy.
Primary Outcome Measure
Satisfaction in Quality of Life as Assessed by the LUP-QOL (Lupus Quality of Life Questionnaire [ Time Frame: Baseline to 12 months post-intervention ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Medical University of South Carolina | Charleston | South Carolina | 29425 | - |
Find similar trials in Charleston, SC
Related Studies
- Systemic Lupus Erythematosus in Gullah HealthRecruiting · Medical University of South Carolina · Charleston, South Carolina
- An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric ParticipantsPHASE3 · Recruiting · AstraZeneca · Phoenix, Arizona
- RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus ErythematosusPHASE1/PHASE2 · Recruiting · Cabaletta Bio · Orange, California
- UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) PatientsPHASE1 · Recruiting · LiveKidney.Bio · Charleston, South Carolina